CINQAIR
CINQAIR
Approved
DIN Number
02456419
Drug Class
Human
Market Date
Dec 19, 2016
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02456419
AIG Number0158290001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
R03DX08 RESLIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification48:10.20
Health Canada Classification
ACTIVE INGREDIENTS (1)
RESLIZUMABActive
Strength: 10 MG / ML
Monograph: RESLIZUMAB